HomeLYEL • NASDAQ
add
Lyell Immunopharma Inc
Previous close
$2.40
Day range
$2.35 - $2.66
Year range
$1.32 - $3.97
Market cap
602.93M USD
Avg Volume
865.94K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
.INX
1.26%
1.00%
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 13.00K | -99.97% |
Operating expense | 59.08M | -6.46% |
Net income | -52.93M | -530.34% |
Net profit margin | -407.15K | -2,346,608.07% |
Earnings per share | -0.17 | -18,378.72% |
EBITDA | -54.01M | -454.73% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 546.22M | -14.67% |
Total assets | 750.03M | -20.00% |
Total liabilities | 95.08M | -8.85% |
Total equity | 654.95M | — |
Shares outstanding | 254.10M | — |
Price to book | 0.93 | — |
Return on assets | -19.12% | — |
Return on capital | -19.95% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -52.93M | -530.34% |
Cash from operations | -40.64M | -0.91% |
Cash from investing | -100.69M | -315.85% |
Cash from financing | 759.00K | -12.05% |
Net change in cash | -140.57M | -2,040.45% |
Free cash flow | -21.22M | -264.11% |
About
Founded
2018
Headquarters
Website
Employees
224